Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.43
Molecular Formula
C21H21FN6O2
Notes
Research use only, not for human use.
Receptor
Ferroptosis
CAS Number
2095668-10-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1028027-01 0.02 mg (E-Coli)
Recombinant Treponema pallidum subsp. pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details 
MBS1028027-02 0.1 mg (E-Coli)
Recombinant Treponema pallidum subsp. pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details 
MBS1028027-03 0.02 mg (Yeast)
Recombinant Treponema pallidum subsp. pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details MBS1028027-04 0.1 mg (Yeast)
Recombinant Treponema pallidum subsp. pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details MBS1028027-05 0.02 mg (Baculovirus)
Recombinant Treponema pallidum subsp. pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details 
MBS1028027-06 0.02 mg (Mammalian-Cell)
Recombinant Treponema pallidum subsp. pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details